EMD-liquid contributes to tissue thickness gain in soft tissue augmentation using a collagen matrix

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Tissue Engineering

Background:

• Enamel matrix derivative (EMD) is used in regenerative therapies.
• EMD is available as a gel (EMD-gel) or liquid (EMD-liquid) formulation.
• Collagen matrices (CM) are utilized as scaffolds in tissue regeneration.

Purpose of the Study:

• To compare the efficacy of EMD-liquid versus EMD-gel in promoting soft tissue regeneration.
• To evaluate the impact of EMD formulations on blood vessel formation (angiogenesis).
• To assess the potential of EMD-liquid as a biologic supplement for collagen matrices.

Main Methods:

• A rat dorsal subcutaneous pouch model was employed.
• Rats were allocated to groups receiving sterile saline + CM, EMD-gel + CM, or EMD-liquid + CM.
• Histomorphometric and immunohistochemical analyses (anti-CD31) were performed at 2 and 4 weeks.

Main Results:

• EMD-liquid + CM demonstrated significantly greater connective tissue thickness at both 2 and 4 weeks compared to other groups.
• The EMD-liquid group exhibited a significantly higher number of blood vessels at 4 weeks.
• No significant differences in multinucleated giant cells were observed among the groups.

Conclusions:

• EMD-liquid pre-primed to CM significantly enhances soft tissue thickness and angiogenesis.
• EMD-liquid serves as an effective biologic supplement, improving the cell-inducing properties of CM scaffolds.
• EMD-liquid offers potential clinical benefits for phenotype modification therapy over CM alone or EMD-gel-treated CM.